Early pregnancy
Conditions
Interventions
A Group:0.15mg/kg Methylphenidate-Rimazolam for Injection
B Group:0.2mg/kg Methylphenidate-Rimazolam for Injection
Sponsors
Sichuan Province Science City Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: 1.undergoing elective abortion; 2.American Society of Anesthesiologists (ASA) I or II; 3.clinically confirmed pregnancy (<12 weeks) by color Doppler ultrasound; 4. 18 ~ 49 years of age; 5.body mass index (BMI) between 18 - 30 kg/m2, no cervical related diseases, no previous cervical surgery.
Exclusion criteria
Exclusion criteria: 1. refusal to participate; 2. ASA Class III or above; 3. hypersensitivity to remazolam or bupropion; 4.severe hepatic/renal/cardiorespiratory/central nervous system dysfunction; 5. duration of a single procedure >10 minutes; 6.and prolonged use of sedative or analgesic medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Propofol dosage;Patient response during cervical dilation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Remazolam dose;Postoperative recovery time of patients; | — |
Countries
China
Contacts
Public ContactYulong Zhong
Sichuan Province Science City Hospital
Outcome results
None listed